000 | 01284 a2200337 4500 | ||
---|---|---|---|
005 | 20250516153147.0 | ||
264 | 0 | _c20140311 | |
008 | 201403s 0 0 eng d | ||
022 | _a2210-3244 | ||
024 | 7 |
_a10.1016/j.gpb.2013.04.003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSt-Coeur, Patrick-Denis | |
245 | 0 | 0 |
_aLeveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas. _h[electronic resource] |
260 |
_bGenomics, proteomics & bioinformatics _cAug 2013 |
||
300 |
_a199-206 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xtherapeutic use |
650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMetabolomics _xmethods |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aTemozolomide |
700 | 1 | _aTouaibia, Mohamed | |
700 | 1 | _aCuperlovic-Culf, Miroslava | |
700 | 1 | _aMorin, Pier | |
773 | 0 |
_tGenomics, proteomics & bioinformatics _gvol. 11 _gno. 4 _gp. 199-206 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.gpb.2013.04.003 _zAvailable from publisher's website |
999 |
_c22804350 _d22804350 |